NACCHO Launches Fracking Project with Associated Webpage and Resources

By Nick Oschman, former NACCHO Environmental Health Intern NACCHO has launched a new webpage to support its project on hydraulic...

Nov 23, 2015 | Guest Author

  • FDA Approves the Fixed-Dose Combination Tablet Genvoya to Treat HIV Infection

    The U.S. Food and Drug Administration (FDA) approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat,...

    Nov 11, 2015 | Alyssa Kitlas

  • CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines

    Last week, the CDC released a press release to welcome the announcement by the World Health Organization (WHO) of new Early Release...

    Oct 08, 2015 | Alyssa Kitlas

  • NACCHO Launches Fracking Project with Associated Webpage and Resources

    By Nick Oschman, former NACCHO Environmental Health Intern NACCHO has launched a new webpage to support its project on hydraulic fracturing—colloquially called fracking—and provide local health departments with the tools, resources, and education they need to protect the health of their communities. Resources will focus on the role local health departments play in fracking education, legislation,...

    Nov 23, 2015 | Guest Author

    FDA Approves the Fixed-Dose Combination Tablet Genvoya to Treat HIV Infection

    The U.S. Food and Drug Administration (FDA) approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. FDA notes: Genvoya is approved for use in HIV-infected adults and children ages 12 […]

    Nov 11, 2015 | Alyssa Kitlas

    CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines

    Last week, the CDC released a press release to welcome the announcement by the World Health Organization (WHO) of new Early Release HIV Treatment and Pre-Exposure Prophylaxis (PrEP) guidelines. This press release stated that these guidelines will significantly increase the number of people eligible for life-saving anti-retroviral treatment (ART) and expand access to a powerful tool for […]

    Oct 08, 2015 | Alyssa Kitlas

    3 Newsletters1200 1
    Back to Top